Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Fortrea Holdings Inc.
Fortrea Holdings Inc. News
Fortrea Holdings Inc. Quantitative Score
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
Fortrea Holdings Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Fortrea Holdings Inc. Financials
Table Compare
Compare FTRE metrics with: | |||
|---|---|---|---|
Earnings & Growth | FTRE | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | FTRE | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | FTRE | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | FTRE | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Fortrea Holdings Inc. Income
Fortrea Holdings Inc. Balance Sheet
Fortrea Holdings Inc. Cash Flow
Fortrea Holdings Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Fortrea Holdings Inc. Executives
| Name | Role |
|---|---|
| Jill McConnell | Chief Financial Officer |
| Mark A. Morais | COO & President of Clinical Services |
| Oren J. Cohen | Chief Medical Officer & President of Clinical Pharmacology |
| Alejandro Martinez Galindo | Chief Information Officer |
| Anshul Thakral | CEO & Director |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Jill McConnell | Chief Financial Officer | Female | 1975 | 521.36K |
| Mark A. Morais | COO & President of Clinical Services | Male | 1977 | 517.09K |
| Oren J. Cohen | Chief Medical Officer & President of Clinical Pharmacology | 1961 | -- | |
| Alejandro Martinez Galindo | Chief Information Officer | Male | -- | |
| Anshul Thakral | CEO & Director | Male | 1978 | -- |
Fortrea Holdings Inc. Insider Trades
| Date | 9 Feb |
| Name | Morais Mark A. |
| Role | Chief Operating Officer |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 2255 |
| Date | 10 Feb |
| Name | Morais Mark A. |
| Role | Chief Operating Officer |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 589 |
| Date | 10 Feb |
| Name | Morais Mark A. |
| Role | Chief Operating Officer |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 590 |
| Date | 9 Feb |
| Name | Morais Mark A. |
| Role | Chief Operating Officer |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 2255 |
| Date | 9 Feb |
| Name | Mcconnell Jill G. |
| Role | Chief Financial Officer |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 1685 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 9 Feb | Morais Mark A. | Chief Operating Officer | Acquired | M-Exempt | 2255 |
| 10 Feb | Morais Mark A. | Chief Operating Officer | Disposed | S-Sale | 589 |
| 10 Feb | Morais Mark A. | Chief Operating Officer | Disposed | S-Sale | 590 |
| 9 Feb | Morais Mark A. | Chief Operating Officer | Disposed | M-Exempt | 2255 |
| 9 Feb | Mcconnell Jill G. | Chief Financial Officer | Acquired | M-Exempt | 1685 |